Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
6.90
-0.41 (-5.61%)
At close: Nov 20, 2026, 4:00 PM EST
6.99
+0.09 (1.25%)
After-hours: Nov 20, 2026, 7:59 PM EST
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $3.19 billion as of November 20, 2026. It is the 4,686th most valuable company in the world and the 1,416th biggest in the United States. Its market cap has increased by 255.85% in one year.
Market Cap
3.19B
Enterprise Value
2.86B
1-Year Change
255.85%
Global Rank
Country Rank
#1,416 United States
Category
ChartMarket Cap Chart
Since February 26, 2015, Iovance Biotherapeutics's market cap has increased from $244.60M to $3.19B, an increase of 1,205.12%. That is a compound annual growth rate of 24.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 3.19B | 194.57% |
| Dec 31, 2025 | 1.08B | -51.95% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 50.98% |
| Feb 26, 2015 | 244.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xenon Pharmaceuticals | 3.71B |
| Tango Therapeutics | 3.71B |
| SELLAS Life Sciences Group | 3.66B |
| Relay Therapeutics | 3.65B |
| AbCellera Biologics | 3.60B |
| Parabilis Medicines | 3.57B |
| Disc Medicine | 3.55B |
| Arcutis Biotherapeutics | 3.49B |